Mild cognitive impairment in older adults

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Mild cognitive impairment (MCI) is the intermediate stage between the cognitive changes of normal aging and dementia. MCI is important because it constitutes a high risk group for dementia. Ideally, prevention strategies should target individuals who are not even symptomatic. Indeed, the field is now moving towards identification of asymptomatic individuals who have underlying Alzheimer's disease (AD) pathology that can be detected using biomarkers and neuroimaging technologies. To this effect, the Alzheimer's Association and the National Institute on Aging have developed a new classification scheme that has categorized AD into a preclinical phase (research category), MCI due to AD, and dementia of Alzheimer's type. However, there are also ongoing research studies to understand high-risk groups for non-Alzheimer's dementia.

Original languageEnglish (US)
Pages (from-to)320-327
Number of pages8
JournalCurrent Psychiatry Reports
Volume14
Issue number4
DOIs
StatePublished - Aug 2012

Fingerprint

Alzheimer Disease
Dementia
National Institute on Aging (U.S.)
Research
Neuroimaging
Biomarkers
Pathology
Technology
Cognitive Dysfunction

Keywords

  • Age-associated cognitive decline
  • Age-associated memory impairment
  • Aging
  • Asymptomatic Alzheimer's disease
  • Benign and malignant forgetfulness
  • Cognitive impairment no dementia
  • Dementia
  • Dementia of Alzheimer's type
  • Mild cognitive impairment
  • Mild neurocognitive decline
  • Neuropsychiatric symptoms
  • Questionable dementia

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Mild cognitive impairment in older adults. / Geda, Yonas Endale.

In: Current Psychiatry Reports, Vol. 14, No. 4, 08.2012, p. 320-327.

Research output: Contribution to journalArticle

@article{a3a041dec9cd4e7190805cd04d678f4a,
title = "Mild cognitive impairment in older adults",
abstract = "Mild cognitive impairment (MCI) is the intermediate stage between the cognitive changes of normal aging and dementia. MCI is important because it constitutes a high risk group for dementia. Ideally, prevention strategies should target individuals who are not even symptomatic. Indeed, the field is now moving towards identification of asymptomatic individuals who have underlying Alzheimer's disease (AD) pathology that can be detected using biomarkers and neuroimaging technologies. To this effect, the Alzheimer's Association and the National Institute on Aging have developed a new classification scheme that has categorized AD into a preclinical phase (research category), MCI due to AD, and dementia of Alzheimer's type. However, there are also ongoing research studies to understand high-risk groups for non-Alzheimer's dementia.",
keywords = "Age-associated cognitive decline, Age-associated memory impairment, Aging, Asymptomatic Alzheimer's disease, Benign and malignant forgetfulness, Cognitive impairment no dementia, Dementia, Dementia of Alzheimer's type, Mild cognitive impairment, Mild neurocognitive decline, Neuropsychiatric symptoms, Questionable dementia",
author = "Geda, {Yonas Endale}",
year = "2012",
month = "8",
doi = "10.1007/s11920-012-0291-x",
language = "English (US)",
volume = "14",
pages = "320--327",
journal = "Current Psychiatry Reports",
issn = "1523-3812",
publisher = "Current Science, Inc.",
number = "4",

}

TY - JOUR

T1 - Mild cognitive impairment in older adults

AU - Geda, Yonas Endale

PY - 2012/8

Y1 - 2012/8

N2 - Mild cognitive impairment (MCI) is the intermediate stage between the cognitive changes of normal aging and dementia. MCI is important because it constitutes a high risk group for dementia. Ideally, prevention strategies should target individuals who are not even symptomatic. Indeed, the field is now moving towards identification of asymptomatic individuals who have underlying Alzheimer's disease (AD) pathology that can be detected using biomarkers and neuroimaging technologies. To this effect, the Alzheimer's Association and the National Institute on Aging have developed a new classification scheme that has categorized AD into a preclinical phase (research category), MCI due to AD, and dementia of Alzheimer's type. However, there are also ongoing research studies to understand high-risk groups for non-Alzheimer's dementia.

AB - Mild cognitive impairment (MCI) is the intermediate stage between the cognitive changes of normal aging and dementia. MCI is important because it constitutes a high risk group for dementia. Ideally, prevention strategies should target individuals who are not even symptomatic. Indeed, the field is now moving towards identification of asymptomatic individuals who have underlying Alzheimer's disease (AD) pathology that can be detected using biomarkers and neuroimaging technologies. To this effect, the Alzheimer's Association and the National Institute on Aging have developed a new classification scheme that has categorized AD into a preclinical phase (research category), MCI due to AD, and dementia of Alzheimer's type. However, there are also ongoing research studies to understand high-risk groups for non-Alzheimer's dementia.

KW - Age-associated cognitive decline

KW - Age-associated memory impairment

KW - Aging

KW - Asymptomatic Alzheimer's disease

KW - Benign and malignant forgetfulness

KW - Cognitive impairment no dementia

KW - Dementia

KW - Dementia of Alzheimer's type

KW - Mild cognitive impairment

KW - Mild neurocognitive decline

KW - Neuropsychiatric symptoms

KW - Questionable dementia

UR - http://www.scopus.com/inward/record.url?scp=84865660409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865660409&partnerID=8YFLogxK

U2 - 10.1007/s11920-012-0291-x

DO - 10.1007/s11920-012-0291-x

M3 - Article

C2 - 22773365

AN - SCOPUS:84865660409

VL - 14

SP - 320

EP - 327

JO - Current Psychiatry Reports

JF - Current Psychiatry Reports

SN - 1523-3812

IS - 4

ER -